Thio HB - Search Results

1

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients.

Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Wakkee M, et al. Among authors: thio hb. Atherosclerosis. 2007 Jan;190(1):1-9. doi: 10.1016/j.atherosclerosis.2006.07.011. Epub 2006 Aug 30. Atherosclerosis. 2007. PMID: 16942772 Review.

2

Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis.

Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Hoefnagel JJ, et al. Among authors: thio hb. Br J Dermatol. 2003 Aug;149(2):363-9. doi: 10.1046/j.1365-2133.2003.05433.x. Br J Dermatol. 2003. PMID: 12932244

3

Psoriasis is not associated with IL-12p70/IL-12p40 production and IL12B promoter polymorphism.

Litjens NH, van der Plas MJ, Ravensbergen B, Numan-Ruberg SC, van Assen Y, Thio HB, van Dissel JT, van de Vosse E, Nibbering PH. Litjens NH, et al. Among authors: thio hb. J Invest Dermatol. 2004 Apr;122(4):923-6. doi: 10.1111/j.0022-202X.2004.22427.x. J Invest Dermatol. 2004. PMID: 15102082

4

[The pathogenesis of inflammatory dermatoses, especially psoriasis].

Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. Bos WE, et al. Among authors: thio hb. Ned Tijdschr Geneeskd. 2006 Jan 28;150(4):179-83. Ned Tijdschr Geneeskd. 2006. PMID: 16471231 Review. Dutch.

5

[New systemic treatments for psoriasis: etanercept, infliximab, adalimumab, efalizumab and alefacept].

Bos WE, Thio HB, Neumann HA, van der Fits L, Prens EP. Bos WE, et al. Among authors: thio hb. Ned Tijdschr Geneeskd. 2006 May 13;150(19):1065-70. Ned Tijdschr Geneeskd. 2006. PMID: 16733982 Review. Dutch.

6

Chronic inflammation in psoriasis and obesity: implications for therapy.

Hamminga EA, van der Lely AJ, Neumann HA, Thio HB. Hamminga EA, et al. Among authors: thio hb. Med Hypotheses. 2006;67(4):768-73. doi: 10.1016/j.mehy.2005.11.050. Epub 2006 Jun 15. Med Hypotheses. 2006. PMID: 16781085

7

Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.

Wakkee M, Lugtenberg M, Spuls PI, de Jong EM, Thio HB, Westert GP, Nijsten T. Wakkee M, et al. Among authors: thio hb. Br J Dermatol. 2008 Aug;159(2):426-32. doi: 10.1111/j.1365-2133.2008.08692.x. Epub 2008 Jul 4. Br J Dermatol. 2008. PMID: 18616791

8

Skin manifestations of diabetes.

Van Hattem S, Bootsma AH, Thio HB. Van Hattem S, et al. Among authors: thio hb. Cleve Clin J Med. 2008 Nov;75(11):772, 774, 776-7 passim. doi: 10.3949/ccjm.75.11.772. Cleve Clin J Med. 2008. PMID: 19068958 Review.

9

Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial.

Fallah Arani S, Neumann H, Hop WC, Thio HB. Fallah Arani S, et al. Among authors: thio hb. Br J Dermatol. 2011 Apr;164(4):855-61. doi: 10.1111/j.1365-2133.2010.10195.x. Epub 2011 Mar 21. Br J Dermatol. 2011. PMID: 21175564 Clinical Trial.

10

Cutaneous adverse events associated with disease-modifying treatment in multiple sclerosis: a systematic review.

Balak DM, Hengstman GJ, Çakmak A, Thio HB. Balak DM, et al. Among authors: thio hb. Mult Scler. 2012 Dec;18(12):1705-17. doi: 10.1177/1352458512438239. Epub 2012 Feb 27. Mult Scler. 2012. PMID: 22371220 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results